Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
Published on: October 6, 2023
Immune drug discovery from venoms.
Rocio Jimenez1, Maria P Ikonomopoulou2, J Alejandro Lopez1
1Griffith University, School of Natural Sciences, Brisbane, Queensland, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Venoms offer novel therapeutic compounds that modulate the immune system for treating diseases like cancer and autoimmune disorders. Future research will identify more immune-modulating agents from venoms.
Area of Science:
- Immunology
- Pharmacology
- Toxicology
Background:
- Venoms are complex biological mixtures with diverse pharmacological activities.
- Recent advances in venomics enable comprehensive analysis of venom components.
- Immune system modulation is a key target for treating various diseases.
Purpose of the Study:
- To review recent advances in venom-derived compounds as therapeutic agents.
- To focus on venom compounds that modulate the immune system.
- To explore the potential of venoms in drug design for immunomodulation.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies on venom components affecting immune cell functions.
- Discussion of venomics and high-throughput screening platforms.
Main Results:
- Venom-derived compounds can affect immune cell numbers, proliferation, migration, phenotype, and cytokine secretion.
- These compounds show potential for up-regulating immune responses in cancer and infections.
- They also show potential for down-regulating immune responses in autoimmune diseases.
Conclusions:
- Venoms are a promising source of novel immunomodulatory compounds.
- Targeting venom-derived pathways can expand the scope of human immunotherapeutics.
- Future venomics and screening efforts will yield numerous potential drug candidates.
More Related Videos
12:16High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
Published on: July 30, 2014
10:25Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
Related Concept Videos
Drug Discovery: Overview
Cross-reactivity
Allergic Drug Reactions
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Drug Toxicity: Allergic Reactions